Keywords: Teva, Second-quarter 2010 financial results
Teva’s 2nd-qtr 2010 profits leap 53%, boosted by strong US sales
Article | 28 July 2010
Israeli generics giant Teva Pharmaceutical Industries posted a massive 53% leap in second-quarter 2010 net profit, excluding one-time items partly due to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
